Market Fallers: AstraZeneca, Diageo, Rentokil Initial, SEGRO

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

The trading price for AstraZeneca with EPIC code: LON:AZN has moved down -1.53% or -134 points throughout today’s trading session so far. Market sellers did not seem confident throughout the trading session. The periods high has reached 8723.45 while the low for the session was 8555. The total volume of shares exchanged so far has reached 694,463 with the average number of shares traded daily being 2,050,811. The 52 week high is 10120 amounting to 1353 points difference from the previous days close and the 52 week low at 5871 is a variance of 2896 points. AstraZeneca now has a 20 simple moving average of 8898.51 and now a 50 day MA at 8753.02. The market capitalisation currently stands at £113,321.33m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for AstraZeneca being recorded at Tuesday, August 4, 2020 at 12:22:54 PM GMT with the stock price trading at 8633 GBX.

The stock price for Diageo ticker lookup code: LON:DGE has stepped down -5.38% or -155 points during the course of today’s session so far. Market sellers have not remained optimistic during the session. Range high for the period so far is 2808 while the low for the session was 2680. The total volume of shares exchanged so far has reached 2,362,843 with the daily average number around 3,397,468. The 52 week high for the share price is 3633.5 which comes in at 752.5 points difference from the previous close and the 52 week low at 2050.6 a difference of some 830.4 points. Diageo now has a 20 moving average of 2829.49 and also a 50 day SMA of 2836.3. The market cap now stands at £63,713.52m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Diageo being recorded at Tuesday, August 4, 2020 at 12:20:34 PM GMT with the stock price trading at 2726 GBX.

Shares of Rentokil Initial ticker lookup code: LON:RTO has dropped -2.25% or -12.4 points during today’s session so far. Investors have so far given a mostly negative outlook during this period. The period high was 554.2 meanwhile the session low reached 534. The total volume traded so far comes to 927,499 while the average shares exchanged is 3,657,381. The 52 week high for the share price is 578 some 27.2 points in difference to the previous days close of business and a 52 week low sitting at 289.2 which is a variance of 261.6 points. Rentokil Initial now has a 20 simple moving average of 549.24 and now its 50 day moving average now of 523.01. The market capitalisation currently stands at £9,983.73m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Rentokil Initial being recorded at Tuesday, August 4, 2020 at 12:20:25 PM GMT with the stock price trading at 538.4 GBX.

The stock price for SEGRO ticker lookup code: LON:SGRO has slid -2.05% or -20 points during today’s session so far. Investors were far from a positive bunch throughout the trading session. The period high was 982 and a low of 954. The volume total for shares traded up to this point was 574,140 whilst the average number of shares exchanged is 2,964,236. A 52 week high for the stock is 982 about 6.4 points difference from the previous close and the 52 week low at 641.8 a difference of some 333.8 points. SEGRO now has a 20 SMA of 942.18 and the 50 day moving average now of 909.78. This puts the market capitalisation now at £11,380.72m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for SEGRO being recorded at Tuesday, August 4, 2020 at 12:19:54 PM GMT with the stock price trading at 955.6 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    AstraZeneca's Imfinzi receives FDA approval for limited-stage small cell lung cancer, marking a significant breakthrough in extending patient survival.
    Rentokil Initial (LON: RTO) announces Paul Edgecliffe-Johnson as new CFO, succeeding Stuart Ingall-Tombs, effective January 1, 2025.

      Search

      Search